Envestnet Asset Management’s ArriVent BioPharma AVBP Stock Holding History

Envestnet Asset Management’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$260K	Buy	+7,472	New	+$221K	﹤0.01%	4510

Other funds holding AVBP

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Envestnet Asset Management's AVBP Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 7,472 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #4510 among its holdings.

24 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

Envestnet Asset Management held 7,472 shares of ArriVent BioPharma worth $260K as of Q2 2026.
ArriVent BioPharma was a new Envestnet Asset Management position in Q2 2026.
ArriVent BioPharma made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4510 holding.
24 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.